WHAT IS THE REAL IMPACT OF THE HLA-DQA1*05 POLYMORPHISM ON INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE?
Joana Revés 1
Ana Catarina Bravo
Eleonora Davoli 2
Chiara Tognini
Ana Guedes 3
Maria Luisa Gloria
Carolina Palmela
Pedro Viana Baptista 2, 2
Alexandra Fernandes 2, 2
Joana Torres
1 Hospital Beatriz Ângelo, Loures, Portugal
2 Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal
3 Glsmed Learning Health Sa, Lisboa, Portugal
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]